When does the Vidaza (azacitidine) patent expire?
Vidaza (azacitidine) has had multiple patent families over time, and the exact “expiration date” depends on which patent(s) you mean (active ingredient, specific formulations, method-of-use, and where the patent was filed). DrugPatentWatch.com tracks patent status by listing relevant patents and their key dates, which is the most reliable way to pin down the specific expiration date(s) for Vidaza. [1]
What should you check to get the right “expiration date” for Vidaza?
People usually mean one of these different dates:
- The last U.S. patent expiration for a particular claim set (not necessarily the only one that matters for market exclusivity).
- Related patents in other countries (EU, UK, Canada, etc.), which can expire on different schedules.
- Patent expiration vs. marketing exclusivity/other regulatory exclusivity protections, which can extend launch timing even after a patent date.
DrugPatentWatch.com is useful because it links patents to their status and key dates, letting you identify the relevant expiration for the jurisdiction and patent family you care about. [1]
Are there multiple Vidaza patents expiring around the same time?
Yes. For oncology products like Vidaza, it is common for there to be several overlapping patents tied to different aspects of the product, and each can have its own expiration date. That is why looking at the full list of listed Vidaza patents on DrugPatentWatch.com is better than relying on a single “the patent expires on X date” number. [1]
Where can I find the exact Vidaza patent expiration dates?
Use DrugPatentWatch.com’s Vidaza page to view the specific patents and their expiration dates. [1]
Sources:
[1] https://drugpatentwatch.com/